As a global health problem, chronic pain is one of the leading causes of
disability, and it imposes a huge economic and public health burden on families and
society. Opioids represent the cornerstone of analgesic drugs. However, opioid
tolerance caused by long-term application of opioids is a major factor leading to drug
withdrawal, serious side effects caused by dose increases, and even the death of
patients, placing an increasing burden on individuals, medicine, and society. Despite
efforts to develop methods to prevent and treat opioid tolerance, no effective
treatment has yet been found. Therefore, understanding the mechanism underlying
opioid tolerance is crucial for finding new prevention and treatment strategies.
Noncoding RNAs (ncRNAs) are important parts of mammalian gene transcriptomes,
and there are thousands of unique noncoding RNA sequences in cells. With the rapid
development of high-throughput genome technology, research on ncRNAs has
become a hot topic in biomedical research. In recent years, studies have shown that
ncRNAs mediate physiological and pathological processes, including chromatin
remodeling, transcription, posttranscriptional modification and signal transduction,
which are key regulators of physiological processes in developmental and disease
environments and have become biomarkers and potential therapeutic targets for
various diseases. An increasing number of studies have found that ncRNAs are
closely related to the development of opioid tolerance. In this review, we have
summarized the evidence that ncRNAs play an important role in opioid tolerance and
that ncRNAs may be novel targets for opioid tolerance.